tiprankstipranks
Sanofi (GB:0O59)
LSE:0O59
UK Market

Sanofi (0O59) Income Statement

Compare
9 Followers

Sanofi Income Statement

Last quarter (Q2 2024), Sanofi's total revenue was €11.38B, an increase of 6.53% from the same quarter last year. In Q2, Sanofi's net income was €1.11B. See Sanofi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 46.03B€ 45.39B€ 39.17B€ 37.37B€ 37.63B
Gross Profit
€ 31.80B€ 31.70B€ 26.92B€ 25.21B€ 25.66B
Operating Expenses
€ 23.94B€ 19.81B€ 17.77B€ 17.32B€ 18.43B
Depreciation and Amortization
€ 3.78B€ 3.70B€ 3.13B€ 3.27B€ 3.75B
EBITDA
€ 12.00B€ 14.06B€ 11.29B€ 17.51B€ 7.11B
Operating Income
€ 7.88B€ 16.79B€ 8.13B€ 8.08B€ 7.69B
Other Income/Expenses
€ -722.00M€ -166.00M€ -328.00M€ 24.00M€ -229.00M
Pretax Income
€ 7.15B€ 10.49B€ 7.80B€ 13.80B€ 2.82B
Net Income
€ 5.40B€ 8.37B€ 6.22B€ 12.29B€ 2.81B
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 4.31€ 6.69€ 4.97€ 9.81€ 2.33
Diluted EPS
€ 4.30€ 6.66€ 4.95€ 9.76€ 2.31
Weighted Average Shares Outstanding
1.25B 1.25B 1.25B 1.25B 1.25B
Weighted Average Shares Outstanding (Diluted)
1.26B 1.26B 1.26B 1.26B 1.26B
Currency in EUR

Sanofi Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis